FDA Adverse Event Injury Summary report: N

CANCELLO-PURE WEDGE

MDR report key: 1669051 · Received April 16, 2010

Report

Report Number
3002719998-2010-00003
Event Type
Injury
Date Received
April 16, 2010
Date of Event
March 8, 2010
Report Date
March 18, 2010
Manufacturer
RTI BIOLOGICS
Product Code
MQV
PMA / PMN Number
K072327
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION: ACCORDING TO THE MFG RECORDS THE GRAFT WAS MFR TO SPECIFICATION. THE GRAFT UNDERWENT TWO VALIDATED STERILIZATION METHODS; BIOCLEANSE AND POST PACKAGING GAMMA IRRADIATION AT A VALIDATED DOSE TO ACHIEVE A STERILITY ASSURANCE LEVEL (SAL) OF 10-6 PRIOR TO RELEASE. RE-REVIEW OF BIOCOMPATIBILITY VALIDATIONS AND COMPARISON OF CURRENT PROCESSING TECHNIQUES, SAMPLES OF REP MFG EPISODES, FOOT/ANKLE LITERATURE REVIEW AND ADDITIONAL INF VIVO AND IN VITRO TESTING OF VARIOUS BOVINE PRODUCTS WAS CONDUCTED. RESULTS OF INVESTIGATION: MANY FACTORS MAY LEAD TO NON-UNION. EXAMPLES INCLUDE DECREASED BLOOD SUPPLY, WEIGHT, INFECTION, POOR GLYCEMIC CONTROL, NONCOMPLIANCE WITH THERAPY, MEDICATIONS (E.G. STEROIDS), ADJUNCT HARDWARE/IMPLANTS, THE PHYSICAL LOCATION OF THE SURGICAL SITE, OR A PROLONGED INFLAMMATORY RESPONSE. CONCLUSION: GRAFTS ASSOCIATED WITH LOT#: 2-080311 PASSED ALL RTI RELEASE CRITERIA PRIOR TO DISTRIBUTION. DEVICE EVALUATION IN PROCESS. TO DATE, THE RESULTS OF OUR INVESTIGATION HAVE NOT IDENTIFIED AN AGENT OR EVENT INTRINSIC TO GRAFT MATERIAL OR PROCESSING METHODOLOGY THAT WOULD CONTRIBUTE TO THE TYPE OF EXPERIENCE REPORTED IN THIS COMPLAINT. A WRITTEN REQUEST FOR ADDITIONAL INFO HAS BEEN SUBMITTED TO THE PHYSICIAN.

Description of Event or Problem · 1

ON (B) (6) 2008, THE PT UNDERWENT A SURGICAL PROCEDURE WHERE A CANCELLO-PURE WEDGE XENOGRAFT WAS IMPLANTED. ON (B) (6) 2010, THE PT UNDERWENT REVISION SURGERY DUE TO NON-UNION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CANCELLO-PURE WEDGE BOVINE BONE VOID FILLER (MQV) MQV RTI BIOLOGICS 2-080311

Patients

Seq Age Sex Outcome Treatment
1 65 YR Required Intervention